420 with CNW — Federally Financed Study Finds Cannabis

New Post Public Reply Private Reply Replies (0) Message Board
NetworkNewsWire
260
420 with CNW — Federally Financed Study Finds Cannabis Legalization Doesn’t Increase Use Among Teens

The cannabis industry has proven to be extremely lucrative, generating billions of dollars in taxes and creating hundreds of thousands of job opportunities. For the past two decades, states across the country have passed legalization measures and allowed cannabis sales to cash in on the profits. More than 20 states now allow adults aged 21 and over to purchase and consume recreational cannabis at registered retailers.

However, efforts to legalize the controversial plant were regularly met with resistance from critics who argued that legalizing cannabis sales would significantly escalate drug use among the youth and lead to increased criminal activity. However, years after states began legalizing cannabis for adult use, studies have repeatedly shown that the wave of cannabis reform hasn’t been associated with an uptick in drug use among the youth.

A new study from a federal drug agency has added to this growing body of research, concluding that there has not been a commensurate increase in youth drug use since states began legalizing marijuana. In the study, researchers analyzed data from three longitudinal studies that looked at past-year marijuana consumption and frequency in adolescents; the data was collected in New York, Washington State and Oregon from 1999 to 2020.Washington legalized cannabis in 2012, and voters in Oregon allowed marijuana in 2014 while New York has yet to begin sales despite approving a legalization measure last year.

As these and other states chose to legalize cannabis, drug reform opponents argued that this would encourage more youth and children to consume cannabis.

Researchers from Colorado State University, Oregon Social Learning Center and the University of Washington have now found that these claims were baseless, concluding that legalization has not resulted in a significant increase in past-year cannabis use. They published their findings in the “American Journal of Protective Medicine.”

The researchers said that their findings, when taken together with prior research on the matter, made it clear that there hasn’t been an upward trend in adolescent cannabis use in the wake of marijuana legalization. They noted that their research expanded on previous studies that came to this same conclusion, such as a study from Michigan State University, which concluded that retail marijuana sales were not associated with increased cannabis use in underage individuals who could not purchase cannabis from registered outlets.

A survey from the Colorado Department of Public Health and Environment also found that cannabis use among young people has dropped dramatically. This countrywide trend is most likely due to stringent controls put in place in legal cannabis outlets to prevent underage patrons from accessing legal cannabis.

These studies confirm that in a way, licensed marijuana companies such as Flora Growth Corp. (NASDAQ: FLGC) are directly and indirectly helping to combat cannabis use by minors in the jurisdictions where marijuana is legal.

NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer


Flora Growth Corp. (FLGC) Stock Research Links

FLGC Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

FutureVault's AI Agents: Transforming Financial Workflows

Updated Category News Views 3

Revolutionizing Financial Operations: FutureVault's AI Approach In the dizzying whirlwind of financial services, the launch of FutureVault AI Agents is a game-changer for document management. This isn't some half-baked tool; it's a full-fledged overhaul of how compliance and operations should tick in the modern age. We've all seen it—a paper trail tangled across systems...

Continue Reading
Compass Unveiled: Power Revolution in Private Equity

Updated Category News Views 5

AI-Driven Insights: Revolutionizing Private Equity Strategies Now this is some spicy news from Huntington Beach! Collective just pulled back the curtain on Compass, their AI-fueled platform that's set to shake up how financial advisors tackle private company equity. If you're an advisor who's sick of staring at nebulous balance sheets filled with unquantifiable private...

Continue Reading
HTX's Strategic Moves in Pakistan: A Crypto Frontier

Updated Category News Views 4

Paving the Way: HTX's Journey in Pakistan Rolling into the Pakistan cryptocurrency scene isn't just a 'walk in the park' for HTX—it's more like traversing a new frontier with an open map. This isn’t some hit-and-run operation; HTX is strategizing for a long haul in one of the liveliest digital market arenas in South Asia. Gathering steam with community AMAs and an X...

Continue Reading
K-Beauty Takes Front Stage at Target Beauty Studio

Updated Category News Views 3

Making Waves in the U.S. with K-Beauty SUNGBOON EDITOR and Milk Touch just rolled into Target Beauty Studio, making a splash in the world of K-beauty. From ingredients that boast serious benefits to playful cosmetics that let you express yourself, these brands are shaking up American beauty routines in a big way. Ingredient-Focused Skincare for Every American Face...

Continue Reading
MRI Surveillance Gains Ground in Lung Cancer Care

Updated Category News Views 7

Shifting the Standard: MRI's Rise in SCLC Treatment Here's a twist that baffles the traditionalists—ditch the prophylactic cranial irradiation (PCI) and catch clearer days with MRI surveillance for small-cell lung cancer (SCLC). The latest international phase III MAVERICK trial might just redraw the lines on what's considered standard care in this relentless disease....

Continue Reading
The Chemical Industry and EPA: A Broken System?

Updated Category News Views 3

Decades of an Unchecked Revolving Door The Environmental Protection Agency (EPA) and chemical manufacturers—a dance that’s been going on for what seems like forever. But not in the way you might hope. We're talking about a revolving door where execs and lobbyists waltz into regulatory chairs while regulators slide into cushy industry gigs. Wisner Baum LLP, a stickler...

Continue Reading
Leapora's Taskeen: Redefining Task Accountability

Updated Category News Views 2

AI's Impact on Workplace Task Management In today’s whirlwind of AI-generated output, transparency is not just a luxury; it’s a necessity. AI systems churn out work that can appear polished but often lacks substance. This doesn't just create headaches; it triggers a ticking bomb in the regulatory department. According to a 2025 survey from Stanford and BetterUp Labs,...

Continue Reading
Regeneron Faces Legal Heat: Lead Plaintiff Deadline Looms

Updated Category News Views 7

Regeneron’s Tight Spot: Legal Showdown Well, here we go again—Regeneron Pharmaceuticals (NASDAQ:REGN) is under some serious heat. If you're an investor who faced significant losses with this biotech juggernaut, remember that the clock’s ticking down to the wire. By tomorrow, September 14, 2026, you need to decide if you're going to throw your hat in the ring for...

Continue Reading
Davos Healthcare Aims to Revolutionize Hospital Ratings

Updated Category News Views 2

Throw away those dusty, old reputation surveys—Davos Healthcare just turned the spotlight onto cold, hard data with its new global hospital evaluation platform. Why Davos Healthcare’s Initiative Matters At the C3 US NYC Davos of Healthcare™ Summit, an event that’s rooted itself alongside the United Nations General Assembly, Davos Healthcare unveiled a...

Continue Reading
Sean Trahan Joins Citrin Cooperman: New Tax Lead

Updated Category News Views 4

Citrin Cooperman's Strategic Tax Move If there's one phrase that can spark a debate at a financial water cooler, it's 'transfer pricing.' Today, Citrin Cooperman is throwing its hat further into that ring with the appointment of Sean Trahan as head of their new Transfer Pricing and Value Chain Optimization Practice. This isn't just another reshuffling of office...

Continue Reading

Top 5 Most Recently Viewed Articles

Liberty Energy Inc. Details Upcoming Financial Results Call

Updated Category News Views 123

Liberty Energy Inc. to Announce Key Financial Outcomes Liberty Energy Inc. (NYSE: LBRT) is preparing to release its financial results for the fourth quarter and full year ending December 31, 2024, just after market close on January 29, 2025. This key announcement will eagerly be anticipated by investors and market analysts alike. Conference Call to Discuss Financial...

Continue Reading
Cambridge Achieves Major Revenue Mark of Over $2 Billion

Updated Category News Views 283

Cambridge Achieves Significant Revenue Milestone Cambridge Investment Research, Inc., a notable player in financial solutions, has recently announced a groundbreaking accomplishment: surpassing $2 billion in annual revenue for the first time. This impressive feat showcases the company's remarkable growth over a short duration, doubling its revenue in just five years. A...

Continue Reading
Elon Musk's Generous Gesture: Free Starlink Terminals for Victims

Updated Category News Views 453

Elon Musk's Commitment to Supporting Wildfire Victims SpaceX CEO Elon Musk recently announced his company’s plan to provide free Starlink terminals to regions experiencing the devastating effects of wildfires. This compassionate initiative aims to support affected communities as they navigate through challenging times. Details of the Initiative In a recent post on his...

Continue Reading
Elevating Leadership at Know Labs for Innovative Solutions

Updated Category News Views 68

Elevating Leadership at Know Labs for Innovative Solutions Know Labs, Inc. (NYSE American: KNW), a pioneering entity in non-invasive diagnostic technology, has announced the addition of two significant leaders to its executive team. John Cronin is stepping into the role of Interim Chief Technology Officer, while Dominic Klyve, Ph.D., will serve as the Chief Science...

Continue Reading
Centrus Energy's New Funding Boosts Advanced Nuclear Projects

Updated Category News Views 176

Critical Funding for Advanced Nuclear Fuel Supply In a significant move towards strengthening the nuclear energy sector, Centrus Energy has announced that its subsidiary, American Centrifuge Operating, LLC, has secured an important award from the U.S. Department of Energy. This funding is dedicated to deploying cutting-edge technology and equipment aimed at converting...

Continue Reading